Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prime Medicine Inc
(NQ:
PRME
)
3.200
+0.230 (+7.74%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prime Medicine Inc
< Previous
1
2
3
4
Next >
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 29, 2024
Via
Benzinga
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
April 29, 2024
Via
Benzinga
Recap: Prime Medicine Q4 Earnings
March 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 29, 2024
Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday!
Via
InvestorPlace
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
April 29, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
April 26, 2024
Via
Benzinga
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
April 23, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
2 Magnificent Growth Stocks With Room to Run
March 27, 2024
These deeply undervalued growth stocks could be big winners for patient shareholders.
Via
The Motley Fool
Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging
March 14, 2024
Explore short-squeeze stocks for potential surges, spotlighting investor strategies and trends that could benefit your portfolio.
Via
InvestorPlace
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
March 01, 2024
On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks.
Via
InvestorPlace
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
March 01, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Participate in Upcoming Investor Conferences
February 28, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
February 20, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Pricing of Upsized Public Offering
February 14, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Proposed Public Offering of Common Stock
February 14, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 01, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
January 25, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
2 gene editing stocks to keep on your 2024 watchlist
January 23, 2024
Gene therapy is receiving much of the spotlight in the medical sector in 2024. The FDA approval for Casgevy, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX)
Via
MarketBeat
Exposures
Product Safety
Morgan Stanley Reports Q4 Results, Joins Boeing, Alcoa And Other Big Stocks Moving Lower On Tuesday
January 16, 2024
U.S. stocks traded lower, with the Dow Jones index falling more than 250 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
January 05, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 22, 2023
Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.
Via
Benzinga
Better Growth Stock: Archer Aviation or Prime Medicine?
December 19, 2023
Which of these innovation-themed growth stocks is the better buy?
Via
The Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.
Via
The Motley Fool
1 Cathie Wood Stock That Could Deliver Life-Changing Returns in 10 Years
November 30, 2023
This gene-editing company could sport a best-in-class platform.
Via
The Motley Fool
Prime Medicine to Present at Upcoming Investor Conferences
November 08, 2023
From
Prime Medicine, Inc.
Via
GlobeNewswire
Ryanair Holdings, Prime Medicine And Other Big Stocks Moving Higher In Monday's Pre-Market Session
November 06, 2023
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 06, 2023
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge...
Via
Benzinga
DISH Network, Goodyear And 3 Stocks To Watch Heading Into Monday
November 06, 2023
With U.S. stock futures trading slightly higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 03, 2023
From
Prime Medicine, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.